Actuate 1901: 9-ING-41 in Myelofibrosis
Clinical trial NCT04218071 · COMPLETED
Trial details
- NCT number
- NCT04218071
- Sponsor
- Actuate Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-20
- Primary completion
- 2022-10-13
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.